ERNALIX Med SPRL
ERNALIX Med reported total assets of 373,042 € at the end of the 2023 financial year (annual accounts filed with the NBB on 02 Jun 2025).
The score of ERNALIX Med shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Equity +34 % Total assets +18 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ERNALIX Med's annual accounts
| 2023 | 2022 | 2021 | 2020 | 2018 | |
|---|---|---|---|---|---|
| Net result | 43,628 € | ||||
| Equity | 328,851 € | ||||
| Cash | 7,338 € | ||||
| EBITDA | 146,021 € | ||||
| Total assets | 373,042 € |
Filed annual accounts
- Year ended 31 Dec 2023filed on 02 Jun 2025
- Year ended 31 Dec 2022filed on 29 Nov 2023
- Year ended 31 Dec 2021filed on 14 Oct 2022
- Year ended 31 Dec 2020filed on 30 Sep 2022
- Year ended 31 Dec 2018filed on 30 Aug 2019
ERNALIX Med's financial analysis
- Solvency88.2%sector median: 65.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ERNALIX Med
ERNALIX Med's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0808.336.533
- VAT number
- BE0808336533
- Peppol
- Registered · 0208:0808336533 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 10 Dec 2008
- Registered office
- 6000 Charleroi
- Latest accounts
- 2023 · filed on 02 Jun 2025
- Activity
- General medical practice activities (NACE 86210)
ERNALIX Med (SPRL) has been based in Charleroi since 2008, active in: general medical practice activities. For 2023, it reports a net profit of 43,628 € and equity of 328,851 €; its revenue is not published. Its solvency stands at 88.2%, above the median of its sector (65.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ERNALIX Med
Companies in the same business, of comparable size and area, outside its group.
- Dr. MARC VANDIJCK General medical practice activities Zoutleeuw · balance sheet 372,905 €
- Maide General medical practice activities Antwerp · balance sheet 372,760 €
- Medisch huis Het Laar General medical practice activities Rumst · balance sheet 372,733 €
- Dr. Sofie Kerkaert General medical practice activities Koksijde · balance sheet 373,499 €
- Huisartsenpraktijk Dr. J.A.J. Quartarone General medical practice activities Sint-Gillis-Waas · balance sheet 373,689 €
- Huisarts Van Renterghem Kwinten General medical practice activities Ghent · balance sheet 372,218 €
- Cabinet Medical Jean-Pierre Amicone General medical practice activities Oupeye · balance sheet 374,195 €
- Comexpe General medical practice activities Uccle · balance sheet 374,378 €
Frequently asked questions about ERNALIX Med
What is the revenue of ERNALIX Med?
ERNALIX Med files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of ERNALIX Med?
In Belgium, the VAT number is the company number prefixed with BE: BE0808336533 for ERNALIX Med, if the company is VAT-registered. Its company number (CBE) is 0808.336.533.
Where is the registered office of ERNALIX Med?
According to the CBE register, the registered office of ERNALIX Med is in 6000 Charleroi.
What is the equity of ERNALIX Med?
At the close of the 2023 financial year, the equity of ERNALIX Med amounts to 328,851 €, a solvency of 88.2% of total assets.
Who manages ERNALIX Med?
The register lists 1 active mandates at ERNALIX Med. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ERNALIX Med
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →